TaraChang United StatesStanford University

TaraChang
Tara I. Chang, MD, MS, is Professor of Medicine and Chief of the Division of Nephrology at Stanford University School of Medicine in Palo Alto, CA. In addition to seeing patients with all types of kidney disease and difficult-to-treat hypertension, Dr. Chang maintains an clinical research program that focuses on improving cardiovascular outcomes among patients with chronic kidney disease. She is a Deputy Editor for the American Journal of Kidney Diseases, and served as a member of the KDIGO Executive Committee and Blood Pressure in CKD Guidelines committee.
Institution

Day 2 - Monday April 15, 2024

Time Session
9 a.m.
10:30 a.m.
Hypertension - the Cutting Edge: Advances in Science and Management
IK03
TaraChang Chairperson tichang@stanford.eduUnited StatesStanford University
Veronica Ferraris Chairperson veronica.ferraris@hospitalitaliano.org.arServicio de Nefrología Pediátrica. Hospital Italiano de Buenos Aires. (Argentina)
  • Behind the Numbers: Exploring the Molecular Mechanisms of Hypertension
    GerardoGamba Speaker gamba@biomedicas.unam.mxMexicoUniversidad Nacional Autónoma de México
  • Hypertension - the Cutting Edge: Is It Time for Sex-specific Management of Hypertension?
    TaliElfassy Speaker t.elfassy@med.miami.eduUnited States
  • State-of-the-Art Treatment of Hypertension in Pediatrics With CKD
    RahulChanchlani Speaker chanchlr@mcmaster.caCanadaMcMaster Children's Hospital, Hamilton, Canada
  • State-of-the-Art Treatment of Hypertension in Adults With CKD
    SusanneNicholas Speaker sunicholas@mednet.ucla.eduUnited StatesDavid Geffen School of Medicine at UCLA
  • Q and A
Hall D

Day 3 - Tuesday April 16, 2024

Time Session
12:30 p.m.
1:30 p.m.
Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120?
IK05
MarceloOrías Chairperson marcelo.orias@gmail.comArgentina
MarkSarnak Chairperson msarnak@tuftsmedicalcenter.orgUnited StatesTufts Medical Center
  • Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - CONS
    JordanaCohen Speaker jco@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania
  • Hot Debate in CKD Hypertension Management: Targeting Systolic BP Below 120? - PROS
    TaraChang Speaker tichang@stanford.eduUnited StatesStanford University
Hall A